About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 702 record(s)
Req # A-2021-001759
Adverse Drug Reactions (ADRs) for PERINDOPRIL ERBUMINE. Report Numbers: 000951224, E2B_03794891. ADR for COVERSYL. Report Number: E2B_03492634.Organization: Health Canada
March 2022
Req # A-2021-001780
Adverse Drug Reactions (ADRs) for CEFIXIME, CLOPIDOGREL BISULFATE. Report Numbers: 000960720, E2B_04447156, E2B_04546577, E2B_04532205, E2B_04546577.Organization: Health Canada
March 2022
Req # A-2021-001796
Adverse Drug Reactions (ADRs) for METFORMIN HYDROCHLORIDE. Report Numbers: E2B_04284040, E2B_04445779, E2B_04501094, E2B_04470794, 000958710, E2B_04168166, 000954460, E2B_04563265, E2B_04168096, E2B_04110358, E2B_04179429, E2B_04250657, E2B_04514920…Organization: Health Canada
March 2022
Req # A-2021-001797
Adverse Drug Reactions (ADRs) for METFORMIN HYDROCHLORIDE. Report Numbers: E2B_04431256, E2B_04438480, E2B_04411181, 000969081, E2B_04116187, E2B_04439714, E2B_04178373, E2B_04414059, E2B_04181634, E2B_04541437, E2B_04593928, E2B_04528744,…Organization: Health Canada
March 2022
Req # A-2021-001823
Adverse Drug Reaction (ADR). Report Number: E2B_04643000.Organization: Health Canada
March 2022
Req # A-2021-001839
Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report Number: E2B_00059136.Organization: Health Canada
March 2022
Req # A-2021-001853
Adverse Drug Reactions (ADRs). Report Numbers: 000970383, 000970385, 000970386.Organization: Health Canada
March 2022
Req # A-2021-001883
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-100222-959.Organization: Health Canada
March 2022
Req # A-2021-001906
Adverse Drug Reactions (ADRs). Report Numbers: 000973282, 000969881, 000969971, 000970998, 000971079, 000971102, 000971408, 000972255, 000972734, 000972735.Organization: Health Canada
March 2022
Req # A-2021-002012
Adverse Drug Reactions (ADRs). Report Numbers: 000973344, 000973805.Organization: Health Canada
March 2022